Compare Calistoga Pharmaceuticals vs Tetraphase Pharmaceuticals
Customers evaluate the quality of Calistoga Pharmaceuticals's products using the following success metrics.
Overview
Calistoga Pharmaceuticals is 18 yrs old and is based in United States.
Calistoga Pharmaceuticals is a biopharmaceutical company developing multiple compounds selectively targeting the PI3K pathway, a pathway known to be involved in certain cancers and inflammatory diseases. In February 2011, Calistoga Pharmaceuticals was acquired by Gilead Sciences. The valuation of Calistoga Pharmaceuticals was $375 million.
Tetraphase Pharmaceuticals is 18 yrs old and is based in United States.
Tetraphase Pharmaceuticals operates as a biopharmaceutical company. It develops and commercializes novel tetracyclines for serious and life-threatening conditions, including bacterial infections caused by multidrug-resistant. Its products include fully synthetic Fluorocyclines and antibiotics for use as first-line empiric monotherapy. The company was founded in 2006 and is based in Watertown, Massachusetts. In July 2020, Tetraphase Pharmaceuticals was acquired by La Jolla Pharmaceuticals.
Demo Video
Leadership
Neill Giese (Chief Security Officer)
Lawrence G. Miller (Founder)
Investors
Gilead Sciences, Frazier Healthcare Partners
La Jolla Pharmaceutical Company, Paycheck Protection Program
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Calistoga Pharmaceuticals has not claimed their profile.
Work for Calistoga Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Calistoga Pharmaceuticals?
Claim your profile now.
Information not available because Tetraphase Pharmaceuticals has not claimed their profile.
Work for Tetraphase Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Tetraphase Pharmaceuticals?
Claim your profile now.